What this means
This is a plan to study body changes linked to aging and long-term diseases in Kazakhstan. No results have been shared yet, so it cannot tell us whether the approach works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 18–69
- Where
- 1 site
The science
- Registered title
- Epigenetics and NCD Prevention in Kazakhstan: Personalized Approaches and Biological Age Prediction
- Trial ID
- NCT06953180 ↗
- Phase
- Not applicable
- Study type
- observational
- Conditions
- Cardiovascular Diseases (CVD), Type 2 Diabetes, Chronic Respiratory Diseases, Obesity (Disorder), Chronic Kidney Diseases
- What is tested
- Genetic: DNA analysis
- Sponsor
- Asfendiyarov Kazakh National Medical University
- Ages
- 18 Years to 69 Years
- Dates
- First posted May 1, 2025 · updated Jul 11, 2025
Registry summary
This study aims to enhance personalized and preventive care for non-communicable diseases (NCDs) in Kazakhstan by examining epigenetic factors, predicting biological age and reproductive function using machine learning, and developing health improvement recommendations.
Sites (1)
- Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan, Kazakhstan